Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.

Item

http://www.wikidata.org/entity/Q47881716

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.

@en

Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.

@nl

type

Item

label

Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.

@en

Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.

@nl

prefLabel

Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.

@en

Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.

@nl

P1476

Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.

@en

P2093

Qinglin Li

http://www.w3.org/2001/XMLSchema#string

Rochelle Frankson

http://www.w3.org/2001/XMLSchema#string

Ruo-Yu Zhang

http://www.w3.org/2001/XMLSchema#string

Yunpeng Bai

http://www.w3.org/2001/XMLSchema#string

Zhi-Hong Yu

http://www.w3.org/2001/XMLSchema#string

Zhong-Yin Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphatase of regenerating liver 2 (PRL2) is essential for placental development by down-regulating PTEN (Phosphatase and Tensin Homologue Deleted on Chromosome 10) and activating Akt protein

Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases

Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)

Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo

Crystal structure of the tyrosine phosphatase SHP-2

PRL-3 expression in metastatic cancers

A phosphatase associated with metastasis of colorectal cancer

Photooxygenation of an amino-thienopyridone yields a more potent PTP4A3 inhibitor.

Targeted deletion of the metastasis-associated phosphatase Ptp4a3 (PRL-3) suppresses murine colon cancer.

Structural Basis of the Oncogenic Interaction of Phosphatase PRL-1 with the Magnesium Transporter CNNM2.

P304

5701-5705

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-17-1510

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28855209

http://www.w3.org/2001/XMLSchema#string

P932

5827927

http://www.w3.org/2001/XMLSchema#string